Lokelma for RAAS Maximisation in CKD & Heart Failure.

Clinical trial NCT05004363 · COMPLETED

Trial details

NCT number: NCT05004363
Sponsor: St George's, University of London
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Chronic Kidney Diseases Heart Failure With Reduced Ejection Fraction Hyperkalemia ACE Inhibitor Induced Hyperkalaemia Mineralocorticoid Resistant Hyperkalemia

Start date: 2022-01-19
Primary completion: 2024-07-01
Enrollment: 112

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.